niflumic acid has been researched along with Stevens-Johnson Syndrome in 2 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raymond, F | 1 |
| Paillat, A | 1 |
| Gambert, C | 1 |
| Garnier, P | 1 |
| de Suremain, N | 1 |
| Le Roux, P | 1 |
| Smith-Xiberras, F | 1 |
| Briquet, MT | 1 |
| Le Luyer, B | 1 |
2 other studies available for niflumic acid and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
[Lyell syndrome following administration of erythromycin-sulfafurazole and morniflumate].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Erythromycin; Female; Humans; Niflumic Ac | 1995 |
[Drug eruptions by niflumic acid].
Topics: Child, Preschool; Female; Humans; Niflumic Acid; Stevens-Johnson Syndrome | 1995 |